Evolent HealthEVH +4.79%60 Median PS Value is $32.01 as of Jun. 24, 2026, which is 15143% above its 10-year median of 0.21. GuruFocus rates EVH with a GF Score™ of 60/100 and a GF Value™ of $11.05 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 264 Healthcare Providers & Services companies, Evolent Health ranks better than 95.83% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Evolent Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $16.674. Evolent Health's 10-Year median PS Ratio is 1.9198. Therefore, the Median PS Value for today is $32.01.
As of today (2026-06-24), Evolent Health's share price is $5.03. Evolent Health's Median PS Value is $32.01. Therefore, Evolent Health's Price to Median PS Value for today is 0.16.
The historical rank and industry rank for Evolent Health's Median PS Value or its related term are showing as below:
EVH'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.07 Med: 0.21 Max: 0.28
Current: 0.16
During the past 13 years, the highest Price to Median PS Value of Evolent Health was 0.28. The lowest was 0.07. And the median was 0.21.
EVH's Price-to-Median-PS-Value is ranked better than 95.83% of 264
companies
in the Healthcare Providers & Services industry
Industry Median: 0.71
vs EVH: 0.16
Evolent Health (NYSE:EVH) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Evolent Health's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
5.03
/
32.01
=
0.16
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health Median PS Value Related Terms
Evolent Health Median PS Value Historical Data
* Premium members only.
The historical data trend for Evolent Health's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVH vs NRC, CTEV, WEAV: Median PS Value Comparison
For the Health Information Services subindustry, Evolent Health's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolent Health Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Evolent Health's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.9198.
Evolent Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $16.674.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health (EVH) has a Median PS Value of $32.01 as of Jun. 24, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Evolent Health and its competitors. This is 15143% above median its historical median of 0.21. Over the past decade, Evolent Health's Median PS Value has ranged from 0.07 to 0.28. According to the industry distribution chart, Evolent Health ranks #11 out of 264 companies in the Healthcare Providers & Services industry, placing it in the top 4.2%.
Is Evolent Health's Median PS Value too high?
Evolent Health's current Median PS Value of $32.01 is 15143% above median its 10-year median of 0.21. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 0.28. The Healthcare Providers & Services industry median Median PS Value is 0.71. Evolent Health's value of $32.01 is 4408.5% above this industry median. Based on the distribution chart, Evolent Health ranks #11 out of 264 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Evolent Health has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Median PS Value compare to NRC and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Evolent Health ranks #11 out of 264 companies for Median PS Value. This places Evolent Health in the top 4% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.71. Evolent Health's value of $32.01 is 4408.5% above this benchmark. Historically, Evolent Health's own Median PS Value has ranged from 0.07 to 0.28 over the past decade. While the company's 10-year median is 0.21 vs. the industry median of 0.71, Evolent Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 264 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evolent Health's current Median PS Value of $32.01 is 4408.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Evolent Health and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evolent Health's current Median PS Value is $32.01, which is 15143% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.05, compared to a current price of $5.03 — trading 54.5% below its estimated fair value. The current Median PS Value is $32.01, which is 15143% above median its 10-year median of 0.21 and 4408.5% above the Healthcare Providers & Services industry median of 0.71. Evolent Health's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Evolent Health (EVH), the current Median PS Value is $32.01 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evolent Health (EVH) Overvalued in 2026?
Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued.
The current stock price of $5.03 is trading 54.5% below its estimated GF Value™ of $11.05.
GuruFocus considers Evolent Health to be Possible Value Trap.
Key valuation signals for EVH:
Median PS Value: $32.01 (15143% above median its 10-year median of 0.21)
GF Value™: $11.05 vs. price of $5.03 (54.5% below fair value)
Industry Position: 4408.5% above the Healthcare Providers & Services median (#11 of 264)
No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
60GF Score
Get the complete analysis for EVH
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVH has been successfully added to your 
